Manuscripts
Showing 1543 manuscripts.
Repeat Pregnancies Among HIV-infected Women Enrolled onto a Clinical Trial: PACTG1022
Citation
Heather D. Watts, Stanley Cohen, Jane Hitti. Repeat Pregnancies Among HIV-infected Women Enrolled onto a Clinical Trial: PACTG1022. Journal of Acquired Immune Deficiency Syndromes. 2009. 51: 231-3. PMID: 19465826Year
2009
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1022
Human immunodeficiency virus diagnostic testing of infants at clinical sites in North America: 2002-2006
Citation
Michael Basar, Gwendolyn Scott, Jennifer S Read, Susan Brogly. Human immunodeficiency virus diagnostic testing of infants at clinical sites in North America: 2002-2006. Pediatric Infectious Disease Journal. 2009. 28: 614-618. PMID: 19478686Year
2009
Journal
Pediatric Infectious Disease Journal
Study
P1025
Early Postpartum Pharmacokinetics (PK) of Lopinavir (LPV) Initiated Intrapartum in Thai Women: a substudy of the International Maternal Pediatric Adolescent AIDS Clinical Trial (IMPAACT) Group P1032 study
Citation
Tim Roy Cressey, Russell B. Van Dyke, Gonzague A. Jourdain, Thanyawee Puthanakit, Anuvat Roongpisuthipong, Jullapong Achalapong, Prapap Yuthavisuthi, Sinart Prommas, Nantasak Chotivanich, Robert T. Maupin, Elizabeth (Betsy) Smith, David E. Shapiro, Mark Mirochnick. Early Postpartum Pharmacokinetics (PK) of Lopinavir (LPV) Initiated Intrapartum in Thai Women: a substudy of the International Maternal Pediatric Adolescent AIDS Clinical Trial (IMPAACT) Group P1032 study. Antimicrobial Agents and Chemotherapy. 2009. 53: 2189-2191. PMID: 19237646Year
2009
Journal
Antimicrobial Agents and Chemotherapy
Study
P1032
Determining an optimal testing strategy for infants at risk for mother-to-child transmission of HIV-1 during the late postnatal period
Citation
Determining an optimal testing strategy for infants at risk for mother-to-child transmission of HIV-1 during the late postnatal period. AIDS and Public Policy Journal. 2009. 22: 2341-6.Year
2009
Journal
AIDS and Public Policy Journal
The use of second generation antipsychotics and the changes in physical growth in children and adolescents with perinatally acquired HIV
Citation
Suad Kapetanovic, Lisa Aaron, Grace Montepiedra, Patricia Sirois, James M. Oleske, Kathleen Malee, Deborah Pearson, Sharon L. Nichols, Patricia A. Garvie, John J. Farley, Molly Nozyce, Mark Mintz, Paige L. Williams. The use of second generation antipsychotics and the changes in physical growth in children and adolescents with perinatally acquired HIV. AIDS Patient Care and STDs. 2009. 23: 939-47. PMID: 19827949Year
2009
Journal
AIDS Patient Care and STDs
Early weaning of HIV-exposed uninfected infants and risk of serious gastroenteritis: findings from two perinatal HIV prevention trials in Kampala, Uganda
Citation
Carol Onyango, Danstan Bagenda, Anthony Mwatha, S. Omer, Philippa Musoke, Francis Mmiro, Sheryl L. Zwerski, Brenda Asiimwe-Kateera, Maria Musisi, Mary Glenn Fowler, Laura A. Guay, Brooks Jackson. Early weaning of HIV-exposed uninfected infants and risk of serious gastroenteritis: findings from two perinatal HIV prevention trials in Kampala, Uganda. Journal of Acquired Immune Deficiency Syndromes. 2009. EPub Ahead of Print. PMID: 19779355Year
2009
Journal
Journal of Acquired Immune Deficiency Syndromes
Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children.
Citation
Myron Levin, Jeffrey Anderson, George Seage, Paige L. Williams. Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children.. Journal of Acquired Immune Deficiency Syndromes. 2009. 50: 182-91. PMID: 19131890Year
2009
Journal
Journal of Acquired Immune Deficiency Syndromes
Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment
Citation
Diane V. Havlir, Richard H. Haubrich, Sharon A. Riddler, Greg DiRienzo, Lauren Komarow, William G. Powderly, Karin L. Klingman, Kevin W. Garren, Tania George, James F. Rooney, Barbara Brizz, Hector Bolivar, Mitchell (Mitch) Goldman, David W. Haas, John W. Mellors. Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment. AIDS. 2009. 23: 1109-18.Year
2009
Journal
AIDS
Peripheral and visceral fat changes following a treatment switch to a non-thymidine analogue or a nucleoside-sparing regimen in HIV-infected subjects with peripheral lipoatrophy: results of ACTG A5110
Citation
Pablo Tebas, Jiameng Zhang, Richard Hafner, Karen T. Tashima, Abby Helen Shevitz, Kevin E. Yarasheski, Baiba Berzins, Susan Owens, Jodi Lee Forand, Scott Evans, Robert L. Murphy. Peripheral and visceral fat changes following a treatment switch to a non-thymidine analogue or a nucleoside-sparing regimen in HIV-infected subjects with peripheral lipoatrophy: results of ACTG A5110. Journal of Antimicrobial Chemotherapy. 2009. 63: 998-1005.Year
2009
Journal
Journal of Antimicrobial Chemotherapy
Delaying a treatment switch in antiretroviral-treated HIV type 1-infected patients with detectable drug-resistant viremia does not have a profound effect on immune parameters: AIDS Clinical Trials Group Study A5115
Citation
Allan R. Tenorio, Hongyu Jiang, Yu (Evelyn) Zheng, Barbara Bastow, Daniel R. Kuritzkes, John Alexander Bartlett, Steven G. Deeks, Alan Landay, Sharon A. Riddler. Delaying a treatment switch in antiretroviral-treated HIV type 1-infected patients with detectable drug-resistant viremia does not have a profound effect on immune parameters: AIDS Clinical Trials Group Study A5115. AIDS Research and Human Retroviruses. 2009. 25: 135-9.Year
2009
Journal
AIDS Research and Human Retroviruses